2017 American Transplant Congress
Impact of Antibiotic Treatment Duration for Symptomatic Lower Urinary Tract Infections in Kidney Transplant Recipients.
University of Michigan, Ann Arbor, MI
Background: Urinary tract infections (UTIs) remain the most common infectious complication post kidney-transplantation and may cause significant morbidity and mortality. Treatment duration for symptomatic lower…2017 American Transplant Congress
Strongyloides Infection in Solid Organ Transplant Recipients: A Single Center Experience and Review of the Literature.
Background: Solid Organ Transplant (SOT) recipients are at risk for Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Most cases are caused by reactivation of latent…2017 American Transplant Congress
Isoflurane Precondition Alleviated Murine Liver Ischemia and Reperfusion Injury by Restoring AMPK/mTOR-Mediated Autophagy.
Background: Isoflurane has a pharmacological precondition effect against ischemia injury in the heart, kidney and brain, but whether and how isoflurane precondition protects livers against…2017 American Transplant Congress
A2 Incompatible Kidney Transplantation: A Single Center Experience.
Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, NY
Background: The new kidney allocation system implemented in December 2014 allowed for use of A2/A2B donors to B recipients. However there is no mandate by…2017 American Transplant Congress
Eculizumab Treatment on GC3 Recurrence on Renal Graft.
Clinical C3G recurrence occured in more than 50% after renal transplantation and is the first cause of allograft loss at 5 years post-transplantation. Eculizumab (EC)…2017 American Transplant Congress
Course of Donor Specific Anti-HLA Antibodies After Induction Therapy with Rituximab in Renal Transplantation.
The presence of pre-existing or de novo donor-specific antibodies against HLA (DSA), is associated with a worse graft outcome after renal transplantation. B-cell depletion protocols…2017 American Transplant Congress
The Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys.
Department of Transplantation, Albert Einstein-Montefiore, Bronx, NY
Purpose: Delayed graft function (DGF) is defined as the need for dialysis within one week of transplantation and occurs in 20-50% of deceased-donor kidney transplant…2017 American Transplant Congress
Outcome of Liver Transplantation in Patients with Prior Bariatric Surgery.
Aim: To study outcomes of liver transplantation (LT) patients with prior bariatric surgery (BS).Methods: Retrospective analysis performed on patients with LT between Jan 2006 and…2017 American Transplant Congress
Pre-Operative Desensitization for Live Donor Liver Transplantation with Strong Donor-Specific Antibodies.
Background: Presence of strong donor-specific antibodies (DSA) (MFI>4000) likely results in uncomplicated short-term outcome in whole liver transplants due to absorption of DSA by the…2017 American Transplant Congress
Heterotopic Auxiliary Liver Transplantation(ALTx) – Revisited.
University of Minnesota, Minneapolis
Background:Although, ALTx for acute liver failure(ALF) has been described over 30yrs ago, utilization of operation has been limited. Benefit of operation is to provide bridge…
- « Previous Page
- 1
- …
- 118
- 119
- 120
- 121
- 122
- …
- 181
- Next Page »